InjectCo provides West Virginia residents with the best weight loss plan, using FDA-approved GLP-1 and GLP-1/GIP medications, all guided by licensed medical providers
Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses
Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy
When a person first starts taking a GLP-1 RA, they gradually ramp up the dose over time
The Australian and New Zealand College of Anaesthetists (ANZCA), the Gastroenterological Society of Australia, the Australian Diabetes Society, and the National Association of Clinical Obesity Services and Australian and New Zealand Metabolic and the Obesity Surgery Society have developed revised recommendations for patients taking GLP-1 receptor agonists and dual GLP-1/GIP receptor co-agonists prior to anaesthesia or sedation
Methods A comprehensive literature search was conducted to synthesize the current preclinical and clinical evidence
